Welcome to LookChem.com Sign In|Join Free
  • or
(5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclic bis(1,2-ethanediyl acetal) is a complex organic compound characterized by a steroid-like structure. It features a norpregnane skeleton, two cyclic bis(1,2-ethanediyl acetal) groups, a dimethylamino-phenyl group, and multiple hydroxyl groups. This unique molecular composition positions it as a potentially interesting candidate for pharmaceutical applications, particularly in the development of hormone-based medications or drugs targeting specific biological pathways.

126690-41-3

Post Buying Request

126690-41-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

126690-41-3 Usage

Uses

Used in Pharmaceutical Industry:
(5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclic bis(1,2-ethanediyl acetal) is used as a precursor or active ingredient in the development of hormone-based medications due to its steroid-like structure and functional groups. Its unique molecular composition allows for potential interactions with biological pathways, making it a promising candidate for further research and development in drug discovery.
Used in Drug Targeting:
In the field of drug targeting, (5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclic bis(1,2-ethanediyl acetal) may be utilized as a targeting moiety for specific biological pathways. Its dimethylamino-phenyl group and hydroxyl groups can potentially facilitate selective binding to target receptors or enzymes, enhancing the efficacy and specificity of the drug.
Used in Drug Delivery Systems:
(5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclic bis(1,2-ethanediyl acetal) can also be employed in the development of drug delivery systems. Its unique structure and functional groups may allow for the design of novel carriers or conjugates that improve the bioavailability, stability, and targeted delivery of therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 126690-41-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,6,9 and 0 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 126690-41:
(8*1)+(7*2)+(6*6)+(5*6)+(4*9)+(3*0)+(2*4)+(1*1)=133
133 % 10 = 3
So 126690-41-3 is a valid CAS Registry Number.

126690-41-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,20-bis-ethylenedioxy-5α,17α-dihydroxy-11β-(4-N,N-dimethylaminophenyl)-19-norpregn-9-ene

1.2 Other means of identification

Product number -
Other names (5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dionecyclicbis(1,2-ethanediylacetal)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:126690-41-3 SDS

126690-41-3Synthetic route

3,3,20,20-bis(ethylenedioxy)-17α-hydroxy-5α,10α-epoxy-19-norpregna-9(11)-ene

3,3,20,20-bis(ethylenedioxy)-17α-hydroxy-5α,10α-epoxy-19-norpregna-9(11)-ene

4-dimethylaminophenylmagnesium bromide
7353-91-5

4-dimethylaminophenylmagnesium bromide

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

Conditions
ConditionsYield
With copper(l) iodide; dimethylsulfide In tetrahydrofuran at 20℃;93%
4-bromo-N,N-dimethylaniline
586-77-6

4-bromo-N,N-dimethylaniline

5α,10α-epoxy-17α-hydroxy-19-norpregn-9(11)-ene-3,20-dione 3,20-bis(ethylene acetal)
54201-83-1

5α,10α-epoxy-17α-hydroxy-19-norpregn-9(11)-ene-3,20-dione 3,20-bis(ethylene acetal)

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

Conditions
ConditionsYield
Stage #1: 4-bromo-N,N-dimethylaniline With 1,1-Dibromoethane; iodine; magnesium In tetrahydrofuran for 1.5h;
Stage #2: 5α,10α-epoxy-17α-hydroxy-19-norpregn-9(11)-ene-3,20-dione 3,20-bis(ethylene acetal) With copper(l) chloride In tetrahydrofuran at 20℃; for 1h; Grignard reaction;
76%
3,3,20,20-bis(ethylene-dioxy)-17α-hydroxy-5,10-epoxy-19-norpregn-9(11)-ene

3,3,20,20-bis(ethylene-dioxy)-17α-hydroxy-5,10-epoxy-19-norpregn-9(11)-ene

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

Conditions
ConditionsYield
Stage #1: 4-bromo-N,N-dimethylaniline With magnesium; ethylene dibromide In tetrahydrofuran at 15 - 50℃; for 2.08333h;
Stage #2: 3,3,20,20-bis(ethylene-dioxy)-17α-hydroxy-5,10-epoxy-19-norpregn-9(11)-ene; copper(l) chloride In tetrahydrofuran; dichloromethane at 15 - 25℃; for 2.75h;
Stage #3: With water; ammonium chloride In tetrahydrofuran; dichloromethane Product distribution / selectivity;
46%
17α-hydroxy-19-norpregna-5(10),9(11)-diene-3,20-dione 3,20-bis(ethylene acetal)
54201-84-2

17α-hydroxy-19-norpregna-5(10),9(11)-diene-3,20-dione 3,20-bis(ethylene acetal)

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 54.3 percent / 30 percent H2O2; (CF3)2CO*3H2O; Na2HPO4 / CH2Cl2 / 7.5 h / 4 °C
2.1: Mg; I2; dibromoethane / tetrahydrofuran / 1.5 h
2.2: 76 percent / CuCl / tetrahydrofuran / 1 h / 20 °C
View Scheme
3,3-(ethylene-dioxy)-17β-cyano-17α-hydroxy-19-norpregna-5(10),9(11)-diene

3,3-(ethylene-dioxy)-17β-cyano-17α-hydroxy-19-norpregna-5(10),9(11)-diene

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 98 percent / DMAP; TEA / tetrahydrofuran / 20 °C
2.1: Li; di-t-butyl biphenyl / tetrahydrofuran / 2.25 h / -70 °C
2.2: HC(OEt)3; p-TsOH / CH2Cl2 / 20 °C
3.1: 54.3 percent / 30 percent H2O2; (CF3)2CO*3H2O; Na2HPO4 / CH2Cl2 / 7.5 h / 4 °C
4.1: Mg; I2; dibromoethane / tetrahydrofuran / 1.5 h
4.2: 76 percent / CuCl / tetrahydrofuran / 1 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1.1: dmap; triethylamine / tetrahydrofuran / 12 h / 5 - 20 °C
2.1: copper(I) bromide / tetrahydrofuran; toluene / 23 h / 20 °C
3.1: orthoformic acid triethyl ester; toluene-4-sulfonic acid / dichloromethane / 18 h / 20 °C
3.2: 0.42 h / 4 °C
4.1: copper(l) iodide; dimethylsulfide / tetrahydrofuran / 20 °C
View Scheme
3,3-ethylenedioxy-17β-cyano-17α-chloromethyl(dimethyl)siloxy estren-5(10),9(11)diene
290825-36-4

3,3-ethylenedioxy-17β-cyano-17α-chloromethyl(dimethyl)siloxy estren-5(10),9(11)diene

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: Li; di-t-butyl biphenyl / tetrahydrofuran / 2.25 h / -70 °C
1.2: HC(OEt)3; p-TsOH / CH2Cl2 / 20 °C
2.1: 54.3 percent / 30 percent H2O2; (CF3)2CO*3H2O; Na2HPO4 / CH2Cl2 / 7.5 h / 4 °C
3.1: Mg; I2; dibromoethane / tetrahydrofuran / 1.5 h
3.2: 76 percent / CuCl / tetrahydrofuran / 1 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: copper(I) bromide / tetrahydrofuran; toluene / 23 h / 20 °C
2.1: orthoformic acid triethyl ester; toluene-4-sulfonic acid / dichloromethane / 18 h / 20 °C
2.2: 0.42 h / 4 °C
3.1: copper(l) iodide; dimethylsulfide / tetrahydrofuran / 20 °C
View Scheme
4-bromo-N,N-dimethylaniline
586-77-6

4-bromo-N,N-dimethylaniline

3,3,20,20-bis(ethylene-dioxy)-17α-hydroxy-5β,10β-epoxy-19-norpregna-9(11)-ene

3,3,20,20-bis(ethylene-dioxy)-17α-hydroxy-5β,10β-epoxy-19-norpregna-9(11)-ene

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

Conditions
ConditionsYield
Stage #1: 4-bromo-N,N-dimethylaniline With magnesium In tetrahydrofuran; dichloromethane at 40 - 50℃; for 3h; Large scale;
Stage #2: 3,3,20,20-bis(ethylene-dioxy)-17α-hydroxy-5β,10β-epoxy-19-norpregna-9(11)-ene With copper(l) chloride In tetrahydrofuran; dichloromethane at 10 - 20℃; for 2h; Cooling with ice; Large scale;
957g
4-bromo-N,N-dimethylaniline
586-77-6

4-bromo-N,N-dimethylaniline

C24H34O6

C24H34O6

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

Conditions
ConditionsYield
With magnesium; copper dichloride In tetrahydrofuran; ethylene dibromide at 10 - 25℃; for 2.5h;
C24H34O5

C24H34O5

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dihydrogen peroxide; pyridine; 1,1,1,3,3,3-hexafluoro-2-propanone trihydrate / dichloromethane / -10 - 5 °C
2: magnesium; copper dichloride / tetrahydrofuran; ethylene dibromide / 2.5 h / 10 - 25 °C
View Scheme
3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

CDB-3236
159811-51-5

CDB-3236

Conditions
ConditionsYield
With sulfuric acid In ethanol for 1h; Heating;88%
Stage #1: 3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene With potassium hydrogensulfate; water at 5℃; for 4h;
Stage #2: With potassium hydroxide; water In dichloromethane Product distribution / selectivity;
With hydrogenchloride; water at 25℃; for 2h;
With hydrogenchloride In water at 25℃; for 2h;
propionic acid
802294-64-0

propionic acid

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

11β-[4-(N,N-dimethylamino)phenyl]-17α-propionyloxy-19-norpregna-4,9-diene-3,10-dione

11β-[4-(N,N-dimethylamino)phenyl]-17α-propionyloxy-19-norpregna-4,9-diene-3,10-dione

Conditions
ConditionsYield
With toluene-4-sulfonic acid; trifluoroacetic anhydride In dichloromethane; water at 0℃; for 1h;47%
3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

ulipristal acetate
126784-99-4

ulipristal acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 88 percent / aq. H2SO4 / ethanol / 1 h / Heating
2: 68 percent / p-TsOH / CH2Cl2 / 0.33 h / 0 °C
View Scheme
acetic anhydride
108-24-7

acetic anhydride

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene
126690-41-3

3,3,20,20-bis(ethylene-dioxy)-5α-17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl-]-19-norpregna-9(11)-ene

ulipristal acetate
126784-99-4

ulipristal acetate

Conditions
ConditionsYield
With perchloric acid; acetic acid In dichloromethane at -10 - 0℃; for 0.5h; Cooling with ice;

126690-41-3Relevant academic research and scientific papers

A practical large-scale synthesis of 17α-acetoxy-11β-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione (CDB-2914)

Rao, Pemmaraju N.,Acosta, C. Kirk,Bahr, Martin L.,Burdett, James E.,Cessac, James W.,Morrison, Paul A.,Kim, Hyun K.

, p. 395 - 400 (2000)

A new practical synthesis of 17α-acetoxy-11β-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione (CDB-2914) is described. The synthesis gives easily isolable solids at all steps and is amenable to large-scale process. Copyright (C) 2000 Elsevier Science Inc.

Preparing acetic acid superior strengthsi Te key intermediate of the new method

-

Paragraph 0027; 0028, (2017/06/30)

The invention discloses a novel preparation method of ulipristal acetate key intermediate 3,3,20,20-double (ethylenedioxy group)-5 alpha, 17 alpha- dihydroxyl-11 bata-[4-(N,N- dimethyl amidogen)- phenyl]-19-norprogesterone-9(11)-alkene, namely 3,3- ethylenedioxy group-17 beta-cyangroup female steroid-5(10), 9(11) diene-17 alpha-alcohol is used as a raw material, through the protection of hydroxyl, the addition of Grignard reagent and cyangroup, and the protection of ketal, and the target compound is obtained finally through 1,4 addition of alpha, beta unsaturation epoxide under the catalysis of a system of cuprous halides and dimethyl sulfide. The raw materials used in the method are safe and reliable, reaction is easy to control, reaction yield and stereoselectivity are high, and the method is applicable for industrial production.

Ulipristal acetate impurities and preparation and detection method thereof

-

, (2016/10/31)

The invention provides ulipristal acetate impurity compounds and a preparation method thereof, and particularly provides novel compound impurities including A (a compound A), G (a compound G), H (a compound H) and J (a compound J). The invention further provides a detection method of the impurities and application of the impurities on quality analysis of an ulipristal acetate bulk drug and a preparation thereof.

ULIPRISTAL ACETATE PREPARATION METHOD AND INTERMEDIATE THEREOF

-

Paragraph 0043, (2014/09/29)

A method as well as new intermediates for preparing Ulipristal acetate (a compound I) and a method for preparing the new intermediates are provided. The intermediate in a constitutional formula IV is conductive to reacting with methyl lithium or methyl Grignard reagent, a protective group is easy to be removed after a reaction, side reactions are few, a mid-term treatment is simple, the reagents used are cheap, costs are low and the yield is high, if a compound in a constitutional formula V is obtained by the reaction of a compound in a constitutional formula III and the intermediate in the constitutional formula IV, the yield of a two-step reaction is 75%, a purity is above 98%. wherein R is defined in the specification.

INDUSTRIAL PROCESS FOR THE SYNTHESIS OF 17α-ACETOXY-11β-[4-(N,N-DIMETHYL-AMINO)- PHENYL]-19-NORPREGNA-4,9-DIENE-3,20-DIONE AND NEW INTERMEDIATES OF THE PROCESS

-

Page/Page column 10; 14, (2008/06/13)

The present invention relates to a new industrial process for the synthesis of solvate- free 17α-acetoxy-11β-[4-(N,N-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione [CDB -2914] of formula (I) which is a strong antiprogestogene and antiglucocorticoid agent. The invention also relates to compounds of formula (VII) and (VIII) used as intermediates in the process. The process according to the invention is the following: i) 3-(ethylene-dioxy)-estra-5(10),9(11)-diene-17-one of formula (X) is reacted with potassium acetilyde formed in situ in dry tetrahydrofuran by known method, ii) the obtained 3-(ethylene-dioxy)-17α-ethynyl-17β-hydroxy-estra-5(10),9(11)-diene of formula (IX) is reacted with phenylsulfenyl chloride in dichloromethane in the presence of triethylamine and acetic acid, iii) the obtained isomeric mixture of 3-(ethylene-dioxy)-21-(phenyl-sulfinyl)-19-norpregna-5(10),9(11),17(20),20-tetraene of formula (VIII) is reacted first with sodium methoxide in methanol, then with trimethyl phosphite, iv) the obtained 3-(ethylene-dioxy)-17α-hydroxy-20-methoxy-19-norpregna-5(10),9(11),20-triene of formula (VII) is reacted with hydrogen chloride in methanol, then v) the obtained 3-(ethylene-dioxy)-17α-hydroxy-19-norpregna-5(10),9(11l)-diene-20- one of formula (VI) is reacted with ethylene glycol hi dichloromethane in the presence of trimethyl orthoformate and p-toluenesulfonic acid by known method, vi) the obtained 3,3,20,20-bis(ethylene-dioxy)-17α-hydroxy-19-norpregna- 5(10),9(11)-diene of formula (V) is reacted with hydrogen peroxide in a mixture of pyridine and dichloromethane in the presence of hexachloroacetone by known method, vii) the obtained 3,3,20,20-bis(ethylene-dioxy)-17α-hydroxy-5,10-epoxy-19-norpregn-9(11)-ene of formula (IV), containing approximately a 1:1 mixture of 5α,10α- and 5β,10β-epoxides, is isolated from the solution and reacted with a Grignard reagent obtained from 4-bromo-N,N-dimethyl-aniline in tetrahydrofuran in the presence of copper(I) chloride catalyst without separation of the isomers by known method, viii) the obtained 3,3,20,20-bis(ethylene-dioxy)-5α,17α-dihydroxy-11β-[4-(N,N-dimethylamino)-phenyl]-19-norpregn-9(11)-ene of formula (III) is reacted with potassium hydrogensulfate in water by known method, ix) the obtained 11β-[4-(N,N-dimethylamino)-phenyl]-17α-hydroxy-19-norpregn-4,9-diene-3,20-dione of formula (II) is acetylated with acetic anhydride in the presence of perchloric acid by known method, finally x) the solvate-free compound of formula (I) is liberated from the obtained solvate containing compound of formula (I) in a 1 : 1 mixture of ethanol and water at 70° C.

11 β-substituted progesterone analogs

-

, (2008/06/13)

A 11β-aryl-19-norprogesterone steroid of the formula: STR1 wherein (i) R1 is H, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, OH, OC(O)CH3, or OC(O)R5, wherein R5 is C2-8 alkyl, C2-8 alkenyl, C2-8 alkynyl or aryl, R2 is H, R3 is H, C1-4 alkyl, C2-4 alkenyl or C2-4 alkynyl, R4 is H, CH3, F or Cl, R6 is H, (CH3)2 N, CH3 O, CH3 CO, CH3 S, CH3 SO, CH3 SO2, and X is O or NOCH3 ; or (ii) R1 and R2 taken together are a carbon-carbon bond and R3, R4, R6 and X are as defined above; or (iii) R1 and R3 taken together are --CH2 -- or --N=N--CH2 --, R2 is H and R4, R6 and X are as defined above; or (iv) R2 and R3 taken together are =CH2 and R1, R4, R6 and X are as defined above.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 126690-41-3